San Diego, CA, United States of America

Robert J Ternansky

USPTO Granted Patents = 35 

 

Average Co-Inventor Count = 2.1

ph-index = 9

Forward Citations = 209(Granted Patents)


Location History:

  • Noblesville, IN (US) (1989 - 1992)
  • Indianapolis, IN (US) (1987 - 1998)
  • Carlsbad, CA (US) (1998 - 2003)
  • San Diego, CA (US) (2004 - 2022)

Company Filing History:


Years Active: 1987-2022

Loading Chart...
Loading Chart...
35 patents (USPTO):Explore Patents

Title: Innovator Robert J. Ternansky: Pioneering Patents in Medical Science

Introduction: Robert J. Ternansky, based in San Diego, CA, is an accomplished inventor with a remarkable portfolio of 35 patents. His contributions primarily focus on medicinal chemistry and innovative treatments for various diseases, particularly those related to cardiovascular health and neurodegenerative disorders.

Latest Patents: Ternansky's latest patents include groundbreaking compounds such as (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives, recognized for their potential as caspase inhibitors to treat multiple diseases, including cardiovascular, kidney, liver, lungs, skin, joints, and autoimmune diseases. In another significant development, he has also focused on compositions and methods for treating beta-amyloid-related diseases, which can help alleviate conditions like Alzheimer's disease and cognitive dysfunction syndrome in both humans and animals. His inventions are designed to provide alternative dosage forms and formulations that are crucial for effective treatment protocols.

Career Highlights: Ternansky has had an impactful career in pharmaceutical innovation, having made substantial contributions while working for prestigious companies such as Eli Lilly and Company and Idun Pharmaceuticals, Inc. His dedication to advancing medical treatments has cemented his reputation as a leading figure in the industry.

Collaborations: Throughout his career, Ternansky has collaborated with notable colleagues such as John Michael Morin, Jr. and Patricia L. Gladstone. These partnerships have allowed him to enhance the scope and effectiveness of his innovations, contributing to successful developments in pharmacology and therapeutics.

Conclusion: Robert J. Ternansky exemplifies a true innovator in the field of medical science. With a robust portfolio of patents and a collaborative spirit, he continues to pave the way for advancements that address pressing health challenges. His work not only signifies a commitment to scientific exploration but also reflects the potential for transformative impact on patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…